After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$644.04K

Vieira Roberto Wandenkolk President, Oncology

Transaction date Sep 2, 2026
Public filing date Sep 3, 2026
Filing lag Filed 1 day later

CORT daily price context

Close on/before transaction
$110.43 Sep 2, 2026
First close after public filing
$111.62 Sep 4, 2026
30-day return after filing
+9.33% Through Oct 5, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
5,621 shares @ $114.58
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001193125-26-382456
Filing cohort

Transactions in this filing

Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$7.75M
Buys / sales
0 / 7
Transactions reported in the same official filing
Issuer Transaction Traded Value
Corcept Therapeutics Inc CORT Exercise Sep 2, 2026 $0
Corcept Therapeutics Inc CORT Sale Sep 2, 2026 $141.41K
Corcept Therapeutics Inc CORT Sale Sep 2, 2026 $2.58M
Corcept Therapeutics Inc CORT Disposition Sep 2, 2026 $11.56K
Corcept Therapeutics Inc CORT Exercise Sep 2, 2026 $1.26M
Corcept Therapeutics Inc CORT Sale Sep 2, 2026 $2.63M
Corcept Therapeutics Inc CORT Sale Sep 2, 2026 $171.18K
Corcept Therapeutics Inc CORT Sale Sep 2, 2026 $109.47K
Corcept Therapeutics Inc CORT Sale Sep 2, 2026 $182.63K
Corcept Therapeutics Inc CORT Current Sale Sep 2, 2026 $644.04K
Corcept Therapeutics Inc CORT Award Sep 1, 2026 $15.65K
Corcept Therapeutics Inc CORT Award Sep 1, 2026 $0